CEFUROXIME vs CEMIPLIMAB-RWLC: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CEFUROXIME vs CEMIPLIMAB-RWLC: Safety Overview
| Metric | CEFUROXIME | CEMIPLIMAB-RWLC |
|---|---|---|
| Total FAERS Reports | 5,209 | 1,554 |
| Deaths Reported | 439 | 323 |
| Death Rate | 8.4% | 20.8% |
| Hospitalizations | 2,274 | 441 |
| Average Patient Age | 56.6 yrs | 70.2 yrs |
| % Female Patients | 45.1% | 40.6% |
| FDA Approval Date | Apr 16, 1998 | N/A |
| Manufacturer | Sagent Pharmaceuticals | N/A |
| Route | INTRAMUSCULAR | N/A |
| Marketing Status | Discontinued | Prescription |